Finance

Lists
QIA:FRA
Qiagen NV
€ 39.01
-1.12%
(-0.44) 1D
9-р сарын 29, 14:44:51 (GMT+2)  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for QIA...
Open
€ 39.32
High
€ 39.32
Low
€ 39.01
Mkt. cap
8.13 тэрбум
Avg. vol.
741.00
Volume
318.00
Dividend
0.79%
Quarterly dividend
€ 0.08
Ex-dividend date
2026 оны 7-р сарын 7
P/E ratio
22.86
52-wk high
€ 48.80
52-wk low
€ 27.86
EPS
€ 1.71
Shares outstanding
226.24 сая
No. of employees
6 мян
Open
€ 39.32
High
€ 39.32
Low
€ 39.01
Mkt. cap
8.13 тэрбум
Avg. vol.
741.00
Volume
318.00
Dividend
0.79%
Quarterly dividend
€ 0.08
Ex-dividend date
2026 оны 7-р сарын 7
P/E ratio
22.86
52-wk high
€ 48.80
52-wk low
€ 27.86
EPS
€ 1.71
Shares outstanding
226.24 сая
No. of employees
6 мян
News stories
From web sources and news partners
Profile
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer. Wikipedia
About Qiagen NV
CEOThierry Bernard
Employees5.5 мян
Founded1984 оны 11-р сарын 29
HeadquartersVenlo, Limburg, Нидерланд
SectorHealth care
Websiteqiagen.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
532.58 сая
540.42 сая
492.32 сая
535.04 сая
Cost of goods sold
187.78 сая
173.92 сая
168.83 сая
181.97 сая
Cost of revenue
187.78 сая
173.92 сая
168.83 сая
181.97 сая
Research and development expenses
48.75 сая
47.24 сая
48.26 сая
50.43 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
143.11 сая
153.88 сая
142.39 сая
146.77 сая
Operating expense
207.51 сая
218.30 сая
206.24 сая
212.22 сая
Total operating expenses
395.29 сая
392.22 сая
375.06 сая
394.19 сая
Operating income
137.29 сая
148.20 сая
117.26 сая
140.85 сая
Other non operating income
-89.00 мян
-133.00 мян
193.00 мян
-35.00 мян
EBT including unusual items
134.73 сая
109.17 сая
85.83 сая
132.10 сая
EBT excluding unusual items
142.86 сая
157.94 сая
118.66 сая
140.05 сая
Income tax expense
4.68 сая
1.34 сая
17.79 сая
28.70 сая
Effective tax rate
3.48%
1.23%
20.72%
21.73%
Other operating expenses
-
-
-
-
Net income
130.04 сая
107.83 сая
68.04 сая
103.40 сая
Net profit margin
24.42%
19.95%
13.82%
19.33%
Earnings per share
-
0.62
0.54
0.62
Interest and investment income
15.07 сая
20.00 сая
10.56 сая
9.36 сая
Interest expense
-8.22 сая
-10.14 сая
-11.05 сая
-10.02 сая
Net interest expenses
6.85 сая
9.86 сая
-489.00 мян
-661.00 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
188.26 сая
179.60 сая
168.47 сая
191.40 сая
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс